These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 34433596)

  • 1. Development and validation of a life expectancy estimator for multimorbid older adults: a cohort study protocol.
    Gastens V; Del Giovane C; Anker D; Feller M; Syrogiannouli L; Schwab N; Bauer DC; Rodondi N; Chiolero A
    BMJ Open; 2021 Aug; 11(8):e048168. PubMed ID: 34433596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and validation of a new prognostic index for mortality risk in multimorbid adults.
    Gastens V; Chiolero A; Anker D; Schneider C; Feller M; Bauer DC; Rodondi N; Giovane CD
    PLoS One; 2022; 17(8):e0271923. PubMed ID: 35930547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rationale and design of OPtimising thERapy to prevent Avoidable hospital admissions in Multimorbid older people (OPERAM): a cluster randomised controlled trial.
    Adam L; Moutzouri E; Baumgartner C; Loewe AL; Feller M; M'Rabet-Bensalah K; Schwab N; Hossmann S; Schneider C; Jegerlehner S; Floriani C; Limacher A; Jungo KT; Huibers CJA; Streit S; Schwenkglenks M; Spruit M; Van Dorland A; Donzé J; Kearney PM; Jüni P; Aujesky D; Jansen P; Boland B; Dalleur O; Byrne S; Knol W; Spinewine A; O'Mahony D; Trelle S; Rodondi N
    BMJ Open; 2019 Jun; 9(6):e026769. PubMed ID: 31164366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular disease and type 2 diabetes in older adults: a combined protocol for an individual participant data analysis for risk prediction and a network meta-analysis of novel anti-diabetic drugs.
    Ribero VA; Alwan H; Efthimiou O; Abolhassani N; Bauer DC; Henrard S; Christiaens A; Waeber G; Rodondi N; Gencer B; Del Giovane C
    medRxiv; 2023 Mar; ():. PubMed ID: 36993427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of 6 Mortality Risk Scores for Prediction of 1-Year Mortality Risk in Older Adults With Multimorbidity.
    Schneider C; Aubert CE; Del Giovane C; Donzé JD; Gastens V; Bauer DC; Blum MR; Dalleur O; Henrard S; Knol W; O'Mahony D; Curtin D; Lee SJ; Aujesky D; Rodondi N; Feller M
    JAMA Netw Open; 2022 Jul; 5(7):e2223911. PubMed ID: 35895059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HOSPITAL Score and LACE Index to Predict Mortality in Multimorbid Older Patients.
    Aubert CE; Rodondi N; Terman SW; Feller M; Schneider C; Oberle J; Dalleur O; Knol W; O'Mahony D; Aujesky D; Donzé J
    Drugs Aging; 2022 Mar; 39(3):223-234. PubMed ID: 35260994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multimorbidity patterns in chronic older patients, potentially inappropriate prescribing and adverse drug reactions: protocol of the multicentre prospective cohort study MoPIM.
    Baré M; Herranz S; Jordana R; Gorgas MQ; Ortonobes S; Sevilla D; De Jaime E; Ibarra O; Martín C;
    BMJ Open; 2020 Jan; 10(1):e033322. PubMed ID: 31988230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing the extent of drug interactions among patients with multimorbidity in primary and secondary care in the West Midlands (UK): a study protocol for the Mixed Methods Multimorbidity Study (MiMMS).
    Backman R; Weber P; Turner AM; Lee M; Litchfield I
    BMJ Open; 2017 Sep; 7(9):e016713. PubMed ID: 28928183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Individualizing life expectancy estimates for older adults using the Gompertz Law of Human Mortality.
    Lee SJ; Boscardin WJ; Kirby KA; Covinsky KE
    PLoS One; 2014; 9(9):e108540. PubMed ID: 25265291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statin therapy in multimorbid older patients with polypharmacy- a cross-sectional analysis of the Swiss OPERAM trial population.
    Adam L; Baretella O; Feller M; Blum MR; Papazoglou DD; Boland B; Aujesky D; Baggio S; Rodondi N
    Front Cardiovasc Med; 2023; 10():1236547. PubMed ID: 37808883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polypharmacy in multimorbid older adults: protocol for a systematic review.
    Sirois C; Laroche ML; Guénette L; Kröger E; Cooper D; Émond V
    Syst Rev; 2017 May; 6(1):104. PubMed ID: 28526062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simplified Mortality Score for the Intensive Care Unit (SMS-ICU): protocol for the development and validation of a bedside clinical prediction rule.
    Granholm A; Perner A; Krag M; Hjortrup PB; Haase N; Holst LB; Marker S; Collet MO; Jensen AK; Møller MH
    BMJ Open; 2017 Mar; 7(3):e015339. PubMed ID: 28279999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of 1-year drug-related admissions in older multimorbid hospitalized adults.
    Aubert CE; Rodondi N; Netzer S; Dalleur O; Spinewine A; Maanen CD; Knol W; O'Mahony D; Aujesky D; Donzé J
    J Am Geriatr Soc; 2022 May; 70(5):1510-1516. PubMed ID: 35064571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a core outcome set for medication review in older patients with multimorbidity and polypharmacy: a study protocol.
    Beuscart JB; Dalleur O; Boland B; Thevelin S; Knol W; Cullinan S; Schneider C; O'Mahony D; Rodondi N; Spinewine A
    Clin Interv Aging; 2017; 12():1379-1389. PubMed ID: 28919724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estonian adverse events study for multimorbid patients using Estonian Trigger Tool (MUPETT-MUltimorbid Patients-Estonian Trigger Tool). Development of Estonian trigger tool for multimorbid patients. A study protocol for mixed-methods study.
    Kannukene A; Orrego C; Lember M; Uusküla A; Põlluste K
    PLoS One; 2023; 18(3):e0280200. PubMed ID: 36928658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes associated with prescribed medications in older adults with multimorbidity: protocol for a scoping review.
    Watt J; Tricco AC; Vyas M; Kohli K; Soin S; Abaeian M; Watt S; Straus SE
    BMJ Open; 2017 Feb; 7(2):e014529. PubMed ID: 28235972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Barriers and enablers for deprescribing among older, multimorbid patients with polypharmacy: an explorative study from Switzerland.
    Zechmann S; Trueb C; Valeri F; Streit S; Senn O; Neuner-Jehle S
    BMC Fam Pract; 2019 May; 20(1):64. PubMed ID: 31088397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient factors associated with new prescribing of potentially inappropriate medications in multimorbid US older adults using multiple medications.
    Jungo KT; Streit S; Lauffenburger JC
    BMC Geriatr; 2021 Mar; 21(1):163. PubMed ID: 33676398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and internal validation of prognostic models to predict negative health outcomes in older patients with multimorbidity and polypharmacy in general practice.
    Müller BS; Uhlmann L; Ihle P; Stock C; von Buedingen F; Beyer M; Gerlach FM; Perera R; Valderas JM; Glasziou P; van den Akker M; Muth C
    BMJ Open; 2020 Oct; 10(10):e039747. PubMed ID: 33093036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protocol for the derivation and external validation of a 30-day mortality risk prediction model for older patients having emergency general surgery (PAUSE score-Probability of mortality Associated with Urgent/emergent general Surgery in oldEr patients score).
    Feng S; Van Walraven C; Lalu M; Moloo H; Musselman R; McIsaac DI
    BMJ Open; 2020 Jan; 10(1):e034060. PubMed ID: 31915174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.